Overview

Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients

Status:
Completed
Trial end date:
2018-10-23
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel design study evaluating a single dose of one of three CA-008 dose levels vs. placebo injected during an elective bunionectomy Bunionectomy to assess post-surgical pain management and the need for rescue medication (oxycodone).
Phase:
Phase 2
Details
Lead Sponsor:
Concentric Analgesics
Treatments:
Acetaminophen
Anti-Inflammatory Agents, Non-Steroidal
Bupivacaine
Ketorolac
Oxycodone